[HTML][HTML] Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related disease and harms from vaccination
N Henschke, H Bergman, G Villanueva… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV‐related
disease and harms from vaccination - PMC Back to Top Skip to main content NIH NLM Logo …
disease and harms from vaccination - PMC Back to Top Skip to main content NIH NLM Logo …
Efficacy of topically administered dihydroartemisinin in treating papillomavirus-induced anogenital dysplasia in preclinical mouse models
LC Gunder, S Blaine-Sauer, HR Johnson, MK Shin… - Viruses, 2022 - mdpi.com
The artemisinin family of compounds is cytopathic in certain cancer cell lines that are
positive for human papillomaviruses (HPV) and can potentially drive the regression of …
positive for human papillomaviruses (HPV) and can potentially drive the regression of …
[HTML][HTML] The impact of broader value elements on cost-effectiveness analysis: two case studies
S Ma, N Olchanski, JT Cohen, DA Ollendorf… - Value in Health, 2022 - Elsevier
Objectives This study aimed to explore the impact of including broader value elements in
cost-effectiveness analyses by presenting 2 case studies, one on human papillomavirus …
cost-effectiveness analyses by presenting 2 case studies, one on human papillomavirus …
[HTML][HTML] Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV‐related diseases: a network meta‐analysis
H Bergman, N Henschke, G Villanueva… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as
follows: We aim to evaluate the safety and e icacy of WHO pre-qualified human …
follows: We aim to evaluate the safety and e icacy of WHO pre-qualified human …